PRESIDENT HAS SERVED AS A REVIEWER FOR THE BST-F (80) BIOENGINEERING ‘ACADEMIC RESEARCH ENHANCEMENT AWARD’ STUDY SECTION FOR THE NIH

PDX Pharma’s President has served as a reviewer for the BST-F (80) Bioengineering ‘Academic Research Enhancement Award’ Study Section for the National Institute of Health (NIH) held on September 14, 2017.

pdx news

  • siRNA therapeutics for breast cancer: recent efforts in targeting metastasis, drug resistance, and immune evasion

    10/9/2019
    read more

  • PRESIDENT SERVES ON SCIENTIFIC REVIEW PANELS FOR THE DOD AND NIH IN NOVEMBER OF 2019

    10/9/2019
    read more

  • PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer published in Cancer Letters

    10/9/2019
    read more

Copyright © 2017 PDX Pharmaceuticals, LLC. All rights reserved